I've stated my opinion on this issue several times. I think, before the HGEN shares were dissolved, American Fiduciary coordinated the transfer of our Humanigen shares to new shares in either Taran or Humanigen Australia, either as part of a stock-for-stock merger, or a 5:1 stock merger. Further, I think our shell remains intact.
"RELIEF REQUESTED 12. Pursuant to the Removal Extension Order, the time within which the Liquidating Trust must file motions to remove any pending civil actions currently is set to expire on September 30, 2024. By this Motion, the Liquidating Trust respectfully requests entry of an order, pursuant to Bankruptcy Rule 9006(b)(1), extending the Removal Deadline for approximately one hundred eighty (180) days through and including March 31, 2025."
"NOTICE OF AGENDA OF MATTERS SCHEDULED FOR HEARING ON AUGUST 21, 2024 AT 11:00 A.M. (ET) THE HEARING HAS BEEN CANCELLED WITH PERMISSION FROM THE COURT AND NO MATTER WILL BE GOING FORWARD."
From that filing, it was interesting to note that, "The Debtor’s mailing address in this chapter 11 case is Humanigen, Inc., c/o Verdolino & Lowey, P.C." I don't know how that may have impacted our relationship with American Fiduciary, if at all.